It seemed like every other day in December the US Food and Drug Administration was either approving a new disease treatment or red-flagging potential issues with a doctor's office staple like exam gloves.MD Magazine
covered these stories, along with additional condition-specific news. Some other highlights from this month included: phase 3 trial results for a potential irritable bowel syndrome drug, an (unexpected?) problem with extended over-the-counter painkiller use, and the Department of Veterans Affairs made a controversial decision on using advanced practice nurses in place of doctors.
Don’t forget to stay up-to-date by connecting with MD Magazine
, and LinkedIn